ANAVEX LIFE SCIENCES CORP. - 8-K Filing

Anavex Life Sciences completed clinical conduct of ADME and DDI studies for blarcamesine, with no serious adverse events reported. (Items: 8.01 Other Events)

3 articles from 1 source · updated October 21, 2026, 07:14 UTC

Coverage

• SUJA LIFE, INC. - 4 Filing SEC EDGAR · October 20, 2026, 20:38 UTC
• Conexeu Sciences Inc. - 8-K Filing SEC EDGAR · October 20, 2026, 20:31 UTC
• ANAVEX LIFE SCIENCES CORP. - 8-K Filing SEC EDGAR · October 20, 2026, 20:17 UTC